文献
J-GLOBAL ID:202202288126167640
整理番号:22A0489302
Fontan手術後の小児における血栓予防に対するリバロキサバンによる投与レジメン予測と確認:第III相UNIVERSE研究からの洞察【JST・京大機械翻訳】
Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study
著者 (14件):
Zhu Peijuan
(Janssen Research & Development, LLC, Raritan, New Jersey, USA)
,
Willmann Stefan
(Bayer AG, Pharmaceuticals, Research and Development, Wuppertal, Germany)
,
Zhou Wangda
(Janssen Research & Development, LLC, Spring House, Pennsylvania, USA)
,
Yang Haitao
(Janssen Research & Development, LLC, Raritan, New Jersey, USA)
,
Michelson Alan D.
(Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA)
,
McCrindle Brian W.
(The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada)
,
Li Jennifer S.
(Duke University Medical Center, Durham, North Carolina, USA)
,
Harris Kevin C.
(Children’s Heart Centre, BC Children’s Hospital, Vancouver, BC, Canada)
,
Pina Liza Miriam
(Janssen Research & Development, LLC, Raritan, New Jersey, USA)
,
Weber Traci
(Janssen Research & Development, LLC, Raritan, New Jersey, USA)
,
Nessel Kimberly
(Janssen Research & Development, LLC, Raritan, New Jersey, USA)
,
Lesko Lawrence J.
(University of Florida College of Pharmacy, Orlando, Florida, USA)
,
Kubitza Dagmar
(Bayer AG, Pharmaceuticals, Research and Development, Wuppertal, Germany)
,
Zannikos Peter
(Janssen Research & Development, LLC, Raritan, New Jersey, USA)
資料名:
Journal of Clinical Pharmacology
(Journal of Clinical Pharmacology)
巻:
62
号:
2
ページ:
220-231
発行年:
2022年
JST資料番号:
B0350B
ISSN:
0091-2700
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)